Login to Your Account



Clinic Roundup


Friday, November 16, 2012
• OncoSec Medical Inc., of San Diego, reported that ImmunoPulse, delivered by electroporation, may give increased levels of interleukin-12 in the microenvironment of tumors in Merkel cell carcinoma. The results were published in the Journal of Immunotherapy, and are scheduled for presentation in a poster. Immunopulse is a DNA-based immunotherapy.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription